We're Here for You!
The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
The IMF stands together with the Black community in calling for justice and racial equality. We believe unconditionally, that Black Lives Matter.
REGISTER for this two-hour webinar featuring a panel discussion about the latest treatments for and management of myeloma led by IMF Chairman Dr. Brian G.M. Durie.
This year’s gathering of the world’s top myeloma experts will convene online August 25-27 due to the pandemic. Despite the challenge of bringing together researchers from a myriad of time zones to a virtual setting, “It is extremely important to help keep myeloma research momentum going,” says IMF Chairman Dr. Brian G.M. Durie.
“On August 5, 2020, the Food and Drug Administration granted accelerated approval to belantamab mafodotin-blmf (Blenrep, GlaxoSmithKline) for adult patients with relapsed or refractory multiple myeloma who have received at least 4 prior therapies, including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent.”
Join us at CAMP IMF, our virtual summer camp for a cure! Go to the IMF’s Facebook page to learn how to participate.
Need to stay informed about the news that impacts myeloma patients, but don’t have time to read everything out there? Then be sure to follow Dr. Brian Durie’s Week in Review blog. The leading myeloma expert and IMF Chairman of the Board drills down on a wide range of topics – from the latest myeloma research results to the environmental issues that offer insight into prevention. He sifts through the data to deliver the bottom line.
The support of loved ones allows us to continue to fund efforts to search for a cure. Check out how Fundraisers are helping in the fight against myeloma.
